Pleasanton, CA | April 9, 2018: FDAzilla, a global leader in FDA intelligence and analytics, announced the addition of Jamie Colgin as GCP Product Manager — further filling out its team of industry experts to include a GCP and data integrity professional. Jamie, hailing from Moorpark, CA and recipient of the prestigious Charles H. Butler Excellence in Teaching Award, will focus on developing FDAzilla’s library of GCP regulatory/enforcement data and analytics tools.
“Sponsors and CROs need more actionable intelligence on FDA inspection activity and trends,” said Michael de la Torre, CEO, FDAzilla. “With Jamie as our GCP and data integrity expert, we’re better equipped to continually improve our tools to enable them to shine a light on FDA risks in their Clinical Operations eco-systems.”
Jamie joins FDAzilla from Colgin Consulting, Inc. where she helps pharmaceutical, biopharmaceutical, and contract research organizations assure the integrity of their clinical data through risk assessments, data integrity audits, mock inspections, remediation assistance, and training.
“I’m very excited to be part of the FDAzilla team as we work together to build up the library of GCP inspectional materials and apply the analytical capabilities my GMP colleagues have relied on for years,” said Jamie.
FDAzilla is the definitive source for FDA inspection data and analytics — with the world’s most comprehensive FDA inspection database, going back to the year 2000 and covering more than 700,000 inspections at 192,000 sites.
The FDAzilla platform takes this unique, unparalleled data set and provides our customers with the data analytics, benchmarking, monitoring services, and inspection documents they need to make better decisions and stay one step ahead of the FDA.
About the Author
Michael de la Torre is the CEO of Govzilla.